[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Takeshi Morimoto\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100465926",false,"NCT05347069","Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization","ASA-IN","Inclusion Criteria:\n\n* Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels\u002Fmajor branches on coronary CT or coronary angiography but not eligible for coronary revascularization\n* Patients for whom consent can be obtained\n\nExclusion Criteria:\n\n* Patients with history of acute coronary syndromes (ACS)\n* Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)\n* Patients with left main trunk stenosis (≥50%)\n* Patients for whom aspirin administration is mandatory\n* Patients undergoing antithrombotic therapy other than aspirin\n* Patients with atrial fibrillation\n* Patients with history of stroke within six months\n* Patients scheduled for major surgical procedures that will require aspirin discontinuation\n* Patients with contraindication of aspirin\n* Patients expected to have a prognosis of 1 year or less due to comorbidities\n* Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization\n* Patients who are judged by attending physicians to be inappropriate to participate in this study","ALL","20 Years",{"count":18,"type":19},2890,"ESTIMATED","INTERVENTIONAL",[22],"PHASE4","The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.",[25,26,27],"Stable Angina Pectoris","Coronary Artery Disease","Ischemic Heart Disease",[29,30],"Chronic Coronary Syndrome","Aspirin","RECRUITING","2025-03-08",{"date":34,"type":35},"2025-03-11","ACTUAL",{"date":37,"type":35},"2022-06-14",{"date":39,"type":19},"2030-12",{"name":41,"class":42},"Takeshi Morimoto","OTHER",""]